vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Take-Two Interactive (TTWO). Click either name above to swap in a different company.
Take-Two Interactive is the larger business by last-quarter revenue ($1.7B vs $950.5M, roughly 1.8× Astrana Health, Inc.). Astrana Health, Inc. runs the higher net margin — 0.7% vs -5.5%, a 6.2% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 24.9%). Take-Two Interactive produced more free cash flow last quarter ($236.2M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 10.2%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Take-Two Interactive Software, Inc. is an American video game holding company based in New York City founded by Ryan Brant in September 1993.
ASTH vs TTWO — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $1.7B |
| Net Profit | $6.6M | $-92.9M |
| Gross Margin | — | 55.7% |
| Operating Margin | 1.9% | -2.3% |
| Net Margin | 0.7% | -5.5% |
| Revenue YoY | 42.9% | 24.9% |
| Net Profit YoY | 184.4% | 25.8% |
| EPS (diluted) | $0.12 | $-0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $1.7B | ||
| Q3 25 | $956.0M | $1.8B | ||
| Q2 25 | $654.8M | $1.5B | ||
| Q1 25 | $620.4M | $1.6B | ||
| Q4 24 | $665.2M | $1.4B | ||
| Q3 24 | $478.7M | $1.4B | ||
| Q2 24 | $486.3M | $1.3B | ||
| Q1 24 | $404.4M | $1.4B |
| Q4 25 | $6.6M | $-92.9M | ||
| Q3 25 | $373.0K | $-133.9M | ||
| Q2 25 | $9.4M | $-11.9M | ||
| Q1 25 | $6.7M | $-3.7B | ||
| Q4 24 | $-7.8M | $-125.2M | ||
| Q3 24 | $16.1M | $-365.5M | ||
| Q2 24 | $19.2M | $-262.0M | ||
| Q1 24 | $14.8M | $-2.9B |
| Q4 25 | — | 55.7% | ||
| Q3 25 | — | 55.3% | ||
| Q2 25 | — | 62.8% | ||
| Q1 25 | — | 50.8% | ||
| Q4 24 | — | 55.9% | ||
| Q3 24 | — | 53.8% | ||
| Q2 24 | — | 57.6% | ||
| Q1 24 | — | 33.5% |
| Q4 25 | 1.9% | -2.3% | ||
| Q3 25 | 2.0% | -5.5% | ||
| Q2 25 | 3.1% | 1.4% | ||
| Q1 25 | 3.3% | -238.7% | ||
| Q4 24 | 0.1% | -9.7% | ||
| Q3 24 | 5.9% | -22.0% | ||
| Q2 24 | 6.2% | -13.8% | ||
| Q1 24 | 7.5% | -193.9% |
| Q4 25 | 0.7% | -5.5% | ||
| Q3 25 | 0.0% | -7.5% | ||
| Q2 25 | 1.4% | -0.8% | ||
| Q1 25 | 1.1% | -235.5% | ||
| Q4 24 | -1.2% | -9.2% | ||
| Q3 24 | 3.4% | -27.0% | ||
| Q2 24 | 3.9% | -19.6% | ||
| Q1 24 | 3.7% | -207.4% |
| Q4 25 | $0.12 | $-0.50 | ||
| Q3 25 | $0.01 | $-0.73 | ||
| Q2 25 | $0.19 | $-0.07 | ||
| Q1 25 | $0.14 | $-21.27 | ||
| Q4 24 | $-0.14 | $-0.71 | ||
| Q3 24 | $0.33 | $-2.08 | ||
| Q2 24 | $0.40 | $-1.52 | ||
| Q1 24 | $0.31 | $-17.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $2.4B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.3M | $3.5B |
| Total Assets | $2.2B | $10.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $2.4B | ||
| Q3 25 | $463.4M | $2.1B | ||
| Q2 25 | $342.1M | $2.0B | ||
| Q1 25 | $260.9M | $1.5B | ||
| Q4 24 | $290.8M | $1.2B | ||
| Q3 24 | $350.3M | $879.6M | ||
| Q2 24 | $327.7M | $1.1B | ||
| Q1 24 | $337.3M | $776.0M |
| Q4 25 | $779.3M | $3.5B | ||
| Q3 25 | $775.5M | $3.4B | ||
| Q2 25 | $765.5M | $3.5B | ||
| Q1 25 | $745.4M | $2.1B | ||
| Q4 24 | $712.7M | $5.7B | ||
| Q3 24 | $704.6M | $5.8B | ||
| Q2 24 | $678.9M | $6.0B | ||
| Q1 24 | $653.5M | $5.7B |
| Q4 25 | $2.2B | $10.0B | ||
| Q3 25 | $2.2B | $10.1B | ||
| Q2 25 | $1.4B | $9.7B | ||
| Q1 25 | $1.3B | $9.2B | ||
| Q4 24 | $1.4B | $12.7B | ||
| Q3 24 | $1.3B | $13.1B | ||
| Q2 24 | $1.3B | $12.9B | ||
| Q1 24 | $1.2B | $12.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $305.2M |
| Free Cash FlowOCF − Capex | $-6.0M | $236.2M |
| FCF MarginFCF / Revenue | -0.6% | 13.9% |
| Capex IntensityCapex / Revenue | 0.3% | 4.1% |
| Cash ConversionOCF / Net Profit | -0.44× | — |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $487.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $305.2M | ||
| Q3 25 | $10.0M | $128.4M | ||
| Q2 25 | $90.9M | $-44.7M | ||
| Q1 25 | $16.6M | $279.0M | ||
| Q4 24 | $-10.9M | $-4.8M | ||
| Q3 24 | $34.0M | $-128.4M | ||
| Q2 24 | $23.2M | $-191.0M | ||
| Q1 24 | $6.0M | $-8.9M |
| Q4 25 | $-6.0M | $236.2M | ||
| Q3 25 | $7.4M | $96.5M | ||
| Q2 25 | $89.5M | $-69.8M | ||
| Q1 25 | $13.6M | $224.9M | ||
| Q4 24 | $-13.5M | $-48.2M | ||
| Q3 24 | $31.7M | $-165.2M | ||
| Q2 24 | $20.4M | $-226.1M | ||
| Q1 24 | $5.6M | $-55.1M |
| Q4 25 | -0.6% | 13.9% | ||
| Q3 25 | 0.8% | 5.4% | ||
| Q2 25 | 13.7% | -4.6% | ||
| Q1 25 | 2.2% | 14.2% | ||
| Q4 24 | -2.0% | -3.5% | ||
| Q3 24 | 6.6% | -12.2% | ||
| Q2 24 | 4.2% | -16.9% | ||
| Q1 24 | 1.4% | -3.9% |
| Q4 25 | 0.3% | 4.1% | ||
| Q3 25 | 0.3% | 1.8% | ||
| Q2 25 | 0.2% | 1.7% | ||
| Q1 25 | 0.5% | 3.4% | ||
| Q4 24 | 0.4% | 3.2% | ||
| Q3 24 | 0.5% | 2.7% | ||
| Q2 24 | 0.6% | 2.6% | ||
| Q1 24 | 0.1% | 3.3% |
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | — | ||
| Q2 25 | 9.65× | — | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 0.40× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
TTWO
Segment breakdown not available.
